Screener
AbbVie ABBV Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 71.5%+0.5pp | 70.7%0.0pp | 70.2%+0.2pp | 69.7%+2.5pp | 70.9%+8.2pp | |
| Operating margin | 26.2%— | 24.4%— | 24.6%— | —— | —— | |
| Net margin | 9.8%+3.3pp | 5.8%-1.5pp | 6.9%-0.7pp | 4%-5.2pp | 6.5%-3.3pp | |
| Valuation | ||||||
| Market capitalization | $435.06B+25.5% | $384.69B+3.8% | $403.83B+28.6% | $409.03B+17.3% | $327.76B+8.2% | |
| Price / earnings | 69×-23.2× | 105.8×+17.5× | 95.6×+22.2× | 171.3×+103× | 87.1×+30.4× | |
| Price / sales | 6.8×+0.8× | 6.1×-0.3× | 6.6×+1.0× | 6.9×+0.6× | 5.6×+0.1× |
FAQ
- What are AbbVie's profit margins?
- AbbVie (ABBV) runs a 71.5% gross margin and a 26.2% operating margin, with a 9.8% net margin.
- Where do AbbVie's ratios come from?
- Every ratio is computed from AbbVie's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
